The Department of Industrial Policy and Promotion in its draft Cabinet has proposed to further tighten the rules for foreign direct investment in brownfield pharmaceutical sector.
Earlier in April, Sun Pharmaceuticals Industries announced acquisition of Ranbaxy in an all-share deal.
The Indian major is eyeing German Merck's generic drug business.
Over 550,000 small drug retailers in the country are transforming into producers and marketers of pharmaceutical products, readying to compete with companies such as Ranbaxy, Cipla, Sun Pharma and Lupin whose produce they sell.
'The obvious opportunity is biosimilars, which are simpler but more expensive,' says Kiran Mazumdar-Shaw, founder of Biocon.
'Staggering of classroom activities to be done, with separate timing slots, to allow for adequate physical distancing and disinfection of classroom premises. Academic scheduling should have an intermix of regular classroom teaching and online teaching and assessments,' the ministry said.
A leading exporter said, there is enough stock of paracetamol in the country. At present, the US, which has become the epicentre of the COVID-19 outbreak, needs paracetamol. He further said India would lose its credibility as the "pharmacy of the world" if it adopts protectionist policies during such a crisis.
India and Brazil raised a trade dispute against the European Union before the World Trade Organization on Tuesday over seizure of generic drugs by EU member countries on high seas.
'He must have had a gala time playing that part.' 'When I got a chance to do that in Toofaan, I absolutely relished it.'
'We have to rise over our divisions.' 'Divisions within us allow unscrupulous politicians to divert attention from issues like corruption and governance.'
The growth prospects are particularly high for Indian companies in the speciality and complex generic drugs segment in the US, the report said.
Indian equities are no longer cheap vis-a-vis global markets, and only a short distance away from being the most expensive they have ever been.
Regulators tighten net on safety grounds.
.jpg)
After a high-level meeting held on Friday chaired by Prime Minister Manmohan Singh, it has been decided that the Commerce and Industry would soon start a consultation process to address 'dangers inherent' in the current model of FDI in brownfield pharma units.
Zydus Pharmaceuticals Inc, the US arm of Zydus Cadila has entered into a strategic alliance with Mallinckrodt Pharmaceuticals Generics, a business unit of Tyco Healthcare to market generic products in the US.
India has airlifted more than 6 million COVID-19 doses to nine countries in Phase-I under its initiative termed "Vaccine Maitri".
Drug firm Strides Acrolab on Tuesday said it is in a position to supply Oseltamivir Capsules, the only available medicine against Influenza A HINI virus (Swine Flu), to meet the demand both from domestic and overseas market.
US firm Mylan NV received a stern warning from the FDA in August for faulty manufacturing practices at three of its India drugmaking plants.
In his press conference on Wednesday, Trump targeted drug-makers and vowed to bring back production in the US.
US District Judge Beryl Howell in Minneapolis denied Ranbaxy's request, the court filing showed.
Calling the FIR against the army as 'unfortunate', Lt Gen Anbu said that there should have been generic FIR in the matter.
The Indian Medical Association and the Mumbai Association of Medical Consultant have written a letter to Narendra Modi expressing disappointment over his statement during the Bharat ki Baat Sabke saath event in London.
This acquisition marks Lupin's foray into the Japanese branded market in-line with aspirations to build business globally.
Indian firm to soon launch copycat of anti-breast-cancer drug.
Last year, the USFDA had banned 30 generic drugs produced at Ranbaxy's plants at Poanta Sahib.
The government plans to rationalise trade margins for many other medical devices, besides stents and knee implants.
Aurobindo pharma, cipla, orchid chemicals are the prominent takeover targets.
Domestic firms Aurobindo Pharma, Glenmark Pharmaceuticals and Natco Pharma have received US health regulator's approval to market their generic Rizatriptan Benzoate orally disintegrating tablets used for treating migraine in the American market.
Drug maker Marksans Pharma on Thursday said it has acquired UK-based generic pharmaceutical company Relonchem for an undisclosed amount.
The US government is threatening to obstruct low-income countries from accessing generic HIV/AIDS drugs approved by the World Health Organization, a human rights group charged on Friday.
Sayre Therapeutics aims for a spot among top 5 players in oncology.
China is on the lookout for investment pastures where its money is welcome, safe and earns a decent return. India also needs vast investment - about $1 trillion over the next 10-15 years - in infrastructure, green energy, transportation and heavy industry, says Ravi Bhoothalingam.
While Watson is a near comparable to Ranbaxy in terms of the generics business in the US, on margins and capital efficiency front, Ranbaxy is way ahead of Watson.
We asked readers to give their reasons as to why Katappa killed Baahubali in the hugely-awaited film Baahubali: The Conclusion, and we got some amazing answers.
Indian pharma firms under European drug regulator's scanner.
India's pharma companies are moving beyond generics to set their sights on the research and development of new drugs, but the risks are many
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances